Inspire Medical Systems, Inc.
Close on Oct 19, 2026
- Market cap
- $2.03B
- P/E (TTM)
- 15.2
- Dividend yield
- –
Earnings
Next report expected Nov 2, 2026, after market close (estimated from past report dates)
| Quarter | Reported | Time | Revenue | EPS (GAAP) | EPS (adjusted) |
|---|---|---|---|---|---|
| Q2 FY2026 Ended Jun 30, 2026 | Aug 3, 2026 | After market close | $200.60M | $0.01 | $0.14 |
| Q1 FY2026 Ended Mar 31, 2026 | May 4, 2026 | After market close | $204.60M | $-0.39 | $0.10 |
| Q4 FY2025 Ended Dec 31, 2025 | Jan 12, 2026 | After market close | – | – | – |
| Q3 FY2025 Ended Sep 30, 2025 | Nov 3, 2025 | After market close | $224.50M | $0.34 | $0.38 |
| Q2 FY2025 Ended Jun 30, 2025 | Aug 4, 2025 | After market close | $217.10M | $-0.12 | $0.45 |
| Q1 FY2025 Ended Mar 31, 2025 | May 5, 2025 | After market close | $201.30M | $0.10 | – |
| Q4 FY2024 Ended Dec 31, 2024 | Jan 13, 2025 | Before market open | – | – | – |
| Q3 FY2024 Ended Sep 30, 2024 | Nov 4, 2024 | After market close | $203.20M | $0.60 | – |
| Q2 FY2024 Ended Jun 30, 2024 | Jul 29, 2024 | Before market open | $195.90M | – | – |
| Q1 FY2024 Ended Mar 31, 2024 | May 7, 2024 | After market close | $164.00M | $-0.34 | – |
| Q4 FY2023 Ended Dec 31, 2023 | Jan 8, 2024 | Before market open | – | – | – |
Company guidance
Outlook given with results on Aug 3, 2026, compared with the previous outlook
| Measure | Period | Guidance | vs. prior |
|---|---|---|---|
| capital expenditures | Full Year 2026 | $35.00M to $40.00M | Lowered |
| adjusted diluted EPSnon-GAAP | Full Year 2026 | $1.05 to $1.45 | Raised |
| diluted EPSGAAP | Full Year 2026 | $-0.42 to $0.17 | Lowered |
| annual adjusted operating marginnon-GAAP | Full Year 2026 | 4% to 6% | Raised |
| estimated weighted average diluted shares outstanding | Full Year 2026 | 29.4 | Maintained |
| effective tax rateGAAP | Full Year 2026 | 95% to 100% | Raised |
| adjusted effective tax ratenon-GAAP | Full Year 2026 | 30% to 35% | Raised |
| revenue | Full Year 2026 | $835.00M to $875.00M | Raised |
Figures and the sentence they come from are taken from the company's earnings release. Hover a measure to read the source sentence.
Press releases
Announcements Inspire Medical Systems filed with the SEC
Inspire Medical Systems, Inc. Announces Second Quarter 2026
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
Inspire Medical Systems, Inc. August 2026 NYSE: INSP
Results of operations · Regulation FD disclosure · EX-99.2 to Form 8-K
Inspire Medical Systems, Inc. Announces First Quarter 2026
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
Inspire Medical Systems, Inc. May 2026 NYSE: INSP
Results of operations · Regulation FD disclosure · EX-99.2 to Form 8-K
Inspire Medical Systems, Inc. Announces Fourth Quarter and
Results of operations · Charter or bylaw amendment · Regulation FD disclosure · EX-99.1 to Form 8-K
Inspire Medical Systems, Inc. February 2026 NYSE: INSP
Results of operations · Charter or bylaw amendment · Regulation FD disclosure · EX-99.2 to Form 8-K
Inspire Medical Systems, Inc. Announces Preliminary Unaudited Revenue Results for the Fourth Quarter and Full Year 2025 and Provides Initial 2026 Revenue Guidance
Results of operations · Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
Inspire Medical Systems, Inc. JP Morgan Healthcare Conference January 12, 2026 NYSE: INSP
Results of operations · Executive or director change · Regulation FD disclosure · EX-99.2 to Form 8-K
Inspire Medical Systems, Inc. Announces Third Quarter 2025
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
Inspire Medical Systems, Inc. November 2025 NYSE: INSP
Results of operations · Regulation FD disclosure · EX-99.2 to Form 8-K
Inspire Medical Systems, Inc. Publishes Inspire V Data at
Regulation FD disclosure · EX-99.1 to Form 8-K
Inspire Medical Systems, Inc. Announces Departure of
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
EX-99.1 to Form 8-K
Other events · EX-99.1 to Form 8-K
Inspire Medical Systems, Inc. Announces Second Quarter 2025
Results of operations · Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
Inspire Medical Systems, Inc. August 2025 NYSE: INSP
Results of operations · Executive or director change · Regulation FD disclosure · EX-99.2 to Form 8-K
© 2024 Inspire Medical Systems, Inc. All Rights Reserved Inspire Medical Systems, Inc. Wells Fargo 2025 MedTech Innovation Spotlight June 13, 2025 NYSE: INSP
Regulation FD disclosure · EX-99.1 to Form 8-K
Inspire Medical Systems, Inc. Announces First Quarter 2025
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
Inspire Medical Systems, Inc. May 2025 NYSE: INSP
Results of operations · Regulation FD disclosure · EX-99.2 to Form 8-K
Inspire Medical Systems, Inc. Announces Fourth Quarter and
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
Inspire Medical Systems, Inc. February 2025 NYSE: INSP
Results of operations · Regulation FD disclosure · EX-99.2 to Form 8-K
Inspire Medical Systems, Inc. Announces Preliminary Results for the Fourth Quarter and Full Year 2024 and Provides Initial 2025 Revenue Guidance
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
enhancing patient lives through sleep innovation I t a l l s tarts and ends wi th our mission We are a medical technology company committed to JP Morgan Investor Update
Results of operations · Regulation FD disclosure · EX-99.2 to Form 8-K
Inspire Medical Systems, Inc. Announces Third Quarter 2024
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
Inspire Medical Systems, Inc. November 2024 NYSE: INSP
Results of operations · Regulation FD disclosure · EX-99.2 to Form 8-K
Inspire Medical Systems, Inc. Announces Second Quarter 2024
Results of operations · Regulation FD disclosure · Other events · EX-99.1 to Form 8-K
Inspire Medical Systems, Inc. August 2024 NYSE: INSP
Results of operations · Regulation FD disclosure · Other events · EX-99.2 to Form 8-K
Inspire Medical Systems, Inc. Inspire Medical Systems, Inc.
Results of operations · Regulation FD disclosure · Other events · EX-99.3 to Form 8-K
Inspire Medical Systems, Inc. Announces FDA Approval of
Other events · EX-99.1 to Form 8-K
Inspire Medical Systems, Inc. Announces Preliminary Results for Second Quarter of 2024 and Updates 2024 Revenue Outlook
Results of operations · EX-99.1 to Form 8-K
Inspire Medical Systems, Inc. Announces First Quarter 2024
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
Inspire Medical Systems, Inc. May 2024 NYSE: INSP
Results of operations · Regulation FD disclosure · EX-99.2 to Form 8-K
Inspire Medical Systems, Inc. Announces Fourth Quarter and
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
© Inspire Medical Systems, Inc. All Rights Reserved INSPIRE CONFIDENTIAL Appendix 21
Results of operations · Regulation FD disclosure · EX-99.2 to Form 8-K
Inspire Medical Systems, Inc. Announces Preliminary Results
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
© Inspire Medical Systems, Inc. All Rights Reserved INSPIRE CONFIDENTIAL Inspire 2023 Year in Review *video 1
Results of operations · Regulation FD disclosure · EX-99.2 to Form 8-K
Inspire Medical Systems, Inc. November 2023 NYSE: INSP 1
Regulation FD disclosure · EX-99.1 to Form 8-K
Inspire Medical Systems, Inc. Announces Third Quarter 2023 Financial Results and Updates 2023 Outlook
Results of operations · EX-99.1 to Form 8-K
Inspire Medical Systems, Inc. August 2023 NYSE: INSP 1
Regulation FD disclosure · EX-99.1 to Form 8-K
Inspire Medical Systems, Inc. Announces Second Quarter 2023 Financial Results and Updates 2023 Outlook
Results of operations · Executive or director change · EX-99.1 to Form 8-K